PNR
72
10
IP
33
3
CINF
41
-9
STI
69
-9
XOM
51
-9
PH
77
3
HCA
35
-9
TXN
40
4
CMS
54
-6
CF
27
-12
COP
51
-2
WRK
59
3
HAL
50
-4
T
41
2
AAL
32
-4
CRM
49
5
PRGO
66
9
AIZ
66
-2
V
66
-2
XRAY
37
2
PNR
72
10
IP
33
3
CINF
41
-9
STI
69
-9
XOM
51
-9
PH
77
3
HCA
35
-9
TXN
40
4
CMS
54
-6
CF
27
-12
COP
51
-2
WRK
59
3
HAL
50
-4
T
41
2
AAL
32
-4
CRM
49
5
PRGO
66
9
AIZ
66
-2
V
66
-2
XRAY
37
2
Financhill
Back

Avenue Therapeutics Stock Predictions

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.
Sell
13

ATXI
Avenue Therapeutics

Last Price:
6.06
Seasonality Move:
-7.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Avenue Therapeutics Stock Forecast

  • Over the next 52 weeks, Avenue Therapeutics has on average historically fallen by 32.9% based on the past 6 years of stock performance.
  • Avenue Therapeutics has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Avenue Therapeutics Stock Undervalued?
    The current Avenue Therapeutics [ATXI] share price is $6.20. The Score for ATXI is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • ATXI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Avenue Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Avenue Therapeutics has on average historically fallen by 32.9% based on the past 6 years of stock performance.

Avenue Therapeutics Stock Rating

Sell
13
Avenue Therapeutics (ATXI) is a Sell

Is Avenue Therapeutics overpriced?

  • Avenue Therapeutics has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Avenue Therapeutics Stock Price History

Is ATXI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
avenuetx.com

52-Week Data

52-Week High:
93.75
52-Week Low:
5.78

Prediction Charts

Market Cap:
3.66M
Price in USD:
6.20
Volume:
226.86K
Beta:
-0.35

Technical Analysis

SMA50:
11.08
SMA100:
11.44
SMA200:
31.26
52-Wk Change:
-90.92%

Stock Predictions

  • Is Avenue Therapeutics stock public?
    Yes, Avenue Therapeutics is a publicly traded company.
  • What is the Avenue Therapeutics stock quote today?
    The Avenue Therapeutics stock price is 6.20 USD today.
  • How to buy Avenue Therapeutics stock online?
    You can buy Avenue Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-9 11.42 11.02 11.42 10.92
Apr-10 11.25 11.22 11.33 10.91
Apr-11 11.22 10.59 11.63 10.13
Apr-12 10.81 10.16 10.85 10.14
Apr-15 10.43 9.38 10.50 8.64
Apr-16 9.31 9.86 10.13 9.18
Apr-17 9.90 10.13 10.43 9.70
Apr-18 10.13 10.10 10.30 9.83
Apr-19 10.11 9.75 10.33 9.38
Apr-22 9.76 9.76 10.31 8.55
Apr-23 9.96 10.05 10.13 9.45
Apr-24 7.88 7.07 7.88 6.68
Apr-25 7.07 8.78 9.00 6.39
Apr-26 7.48 6.20 8.99 5.78

Avenue Therapeutics Earnings

Avenue Therapeutics Earnings Report: Per Share Avenue Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Avenue Therapeutics Forecast Revenue Growth

Avenue Therapeutics Stock Analysis: Historical quarterly revenues per share for Avenue Therapeutics and historical quarterly revenue growth:

* Avenue Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.